172 related articles for article (PubMed ID: 23332896)
1. Diagnostic value of a heart-type fatty acid-binding protein (H-FABP) bedside test in suspected acute coronary syndrome in primary care.
Bruins Slot MH; Rutten FH; van der Heijden GJ; Doevendans PA; Mast EG; Bredero AC; van der Spoel OP; Glatz JF; Hoes AW
Int J Cardiol; 2013 Sep; 168(2):1485-9. PubMed ID: 23332896
[TBL] [Abstract][Full Text] [Related]
2. Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: optimal cut-off point, diagnostic value and future opportunities in primary care.
Willemsen RT; van Severen E; Vandervoort PM; Grieten L; Buntinx F; Glatz JF; Dinant GJ
Eur J Gen Pract; 2015; 21(3):156-63. PubMed ID: 25751665
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of quantitative heart-fatty acid binding protein assays compared with Cardiodetect(®) in the early detection of acute coronary syndrome.
Charpentier S; Maupas-Schwalm F; Cournot M; Elbaz M; Ducassé JL; Bottela JM; Lauque D
Arch Cardiovasc Dis; 2011 Oct; 104(10):524-9. PubMed ID: 22044705
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.
Figiel Ł; Wraga M; Bednarkiewicz Z; Lipiec P; Smigielski J; Krzemińska-Pakuła M; Kasprzak JD
Kardiol Pol; 2011; 69(1):1-6. PubMed ID: 21267954
[TBL] [Abstract][Full Text] [Related]
5. Suspected acute coronary syndrome in the emergency room: Limited added value of heart type fatty acid binding protein point of care or ELISA tests: The FAME-ER (Fatty Acid binding protein in Myocardial infarction Evaluation in the Emergency Room) study.
Bank IE; Dekker MS; Hoes AW; Zuithoff NP; Verheggen PW; de Vrey EA; Wildbergh TX; Timmers L; de Kleijn DP; Glatz JF; Mosterd A
Eur Heart J Acute Cardiovasc Care; 2016 Aug; 5(4):364-74. PubMed ID: 25906779
[TBL] [Abstract][Full Text] [Related]
6. The value of signs, symptoms and plasma heart-type fatty acid-binding protein (H-FABP) in evaluating patients presenting with symptoms possibly matching acute coronary syndrome: background and methods of a diagnostic study in primary care.
Willemsen RT; Buntinx F; Winkens B; Glatz JF; Dinant GJ;
BMC Fam Pract; 2014 Dec; 15():203. PubMed ID: 25738970
[TBL] [Abstract][Full Text] [Related]
7. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of heart-type fatty acid binding protein determined by the rapid qualitative chromatographic immunoassay method for the detection of minor myocardial damage in patients presenting with non-ST elevation acute coronary syndrome.
Çavuşoğlu Y; Gök B; Demirüstü C; Birdane A; Görenek B; Ata N
Anadolu Kardiyol Derg; 2012 Nov; 12(7):584-90. PubMed ID: 22804980
[TBL] [Abstract][Full Text] [Related]
9. Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department.
Charpentier S; Ducassé JL; Cournot M; Maupas-Schwalm F; Elbaz M; Baixas C; Juchet H; Lang T; Lauque D
Acad Emerg Med; 2010 Jan; 17(1):27-35. PubMed ID: 20078436
[TBL] [Abstract][Full Text] [Related]
10. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
Viswanathan K; Kilcullen N; Morrell C; Thistlethwaite SJ; Sivananthan MU; Hassan TB; Barth JH; Hall AS
J Am Coll Cardiol; 2010 Jun; 55(23):2590-8. PubMed ID: 20513600
[TBL] [Abstract][Full Text] [Related]
11. Heart fatty acid binding protein (H-FABP) as a diagnostic biomarker in patients with acute coronary syndrome.
Gururajan P; Gurumurthy P; Nayar P; Srinivasa Nageswara Rao G; Babu S; Cherian KM
Heart Lung Circ; 2010 Nov; 19(11):660-4. PubMed ID: 20674495
[TBL] [Abstract][Full Text] [Related]
12. Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome.
Valle HA; Riesgo LG; Bel MS; Gonzalo FE; Sanchez MS; Oliva LI
Eur J Emerg Med; 2008 Jun; 15(3):140-4. PubMed ID: 18460953
[TBL] [Abstract][Full Text] [Related]
13. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.
Kilcullen N; Viswanathan K; Das R; Morrell C; Farrin A; Barth JH; Hall AS;
J Am Coll Cardiol; 2007 Nov; 50(21):2061-7. PubMed ID: 18021874
[TBL] [Abstract][Full Text] [Related]
14. Value of heart-type fatty acid-binding protein (H-FABP) for emergency department patients with suspected acute coronary syndrome.
Banu KY; Niyazi OD; Erdem C; Dpekçi Afşin DH; Ozlem U; Yasemin C; Afsin I
Afr Health Sci; 2014 Sep; 14(3):757-62. PubMed ID: 25352899
[TBL] [Abstract][Full Text] [Related]
15. The role of the heart-type fatty acid binding protein in the early diagnosis of acute coronary syndrome and its comparison with troponin I and creatine kinase-MB isoform.
Orak M; Ustündağ M; Güloğlu C; Ozhasenekler A; Alyan O; Kale E
Am J Emerg Med; 2010 Oct; 28(8):891-6. PubMed ID: 20825920
[TBL] [Abstract][Full Text] [Related]
16. Point-of-care heart-type fatty acid binding protein versus high-sensitivity troponin T testing in emergency patients at high risk for acute coronary syndrome.
Kellens S; Verbrugge FH; Vanmechelen M; Grieten L; Van Lierde J; Dens J; Vrolix M; Vandervoort P
Eur Heart J Acute Cardiovasc Care; 2016 Apr; 5(2):177-84. PubMed ID: 25666938
[TBL] [Abstract][Full Text] [Related]
17. [Heart-type fatty acid-binding protein detection for early diagnosis of acute coronary syndrome].
Zhang P; Wang Q; Zheng L; Zeng FY; Qiu YR
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):358-60. PubMed ID: 16546748
[TBL] [Abstract][Full Text] [Related]
18. Heart-type fatty acid binding protein and the diagnosis of acute coronary syndrome in the ED.
Freund Y; Chenevier-Gobeaux C; Leumani F; Claessens YE; Allo JC; Doumenc B; Cosson C; Bonnet P; Riou B; Ray P
Am J Emerg Med; 2012 Oct; 30(8):1378-84. PubMed ID: 22169585
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage.
Kume N; Mitsuoka H; Hayashida K; Tanaka M
J Cardiol; 2011 Jul; 58(1):38-45. PubMed ID: 21616640
[TBL] [Abstract][Full Text] [Related]
20. Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction.
Mad P; Domanovits H; Fazelnia C; Stiassny K; Russmüller G; Cseh A; Sodeck G; Binder T; Christ G; Szekeres T; Laggner A; Herkner H
QJM; 2007 Apr; 100(4):203-10. PubMed ID: 17347171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
